INFINITY PHARMACEUTICALS, INC. 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed Nov 28, 2014
Insider Transaction Report
Form 4
Palombella Vito J.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2014-11-26$15.00/sh−4,736$71,040→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2014-11-26−4,736→ 0 totalExercise: $2.04From: 2005-05-10Exp: 2015-05-10→ Common Stock (4,736 underlying) - Exercise/Conversion
Common Stock
2014-11-26$2.04/sh+4,736$9,661→ 4,736 total
Holdings
- 6,543.802(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The acquisition and disposition reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2013.
- [F2]The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2013.
- [F3]This stock option was granted under the issuer's Pre-Merger Stock Incentive Plan, which permits the early exercise of unvested stock options in exchange for shares of restricted stock that are subject to a right of repurchase by the issuer that lapses in accordance with the vesting schedule of the original option. This option is fully vested.